PODD vs ZBIO · P/E 34, rev $1.56B vs rev $10.0M
Insulet Corporation (PODD) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the PODD and ZBIO stock pages for the full models.
Not investment advice.